Categories AlphaGraphs, Earnings, Health Care
Infographic: How Abbott Laboratories (ABT) performed in Q4 2022 financial results
Abbott Laboratories (NYSE: ABT) reported fourth quarter 2022 earnings results today.
Net sales declined 12% year-over-year to $10.1 billion.
Net earnings decreased 48% to $1 billion while EPS fell 47% to $0.59. Adjusted earnings were down 23% to $1.8 billion while adjusted EPS dropped 22% to $1.03.
Abbott expects adjusted EPS from continuing operations to be $4.30-4.50 for the full year of 2023.
Prior performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Key metrics from Chewy’s (CHWY) Q4 2024 earnings results
Chewy, Inc. (NYSE: CHWY) reported its fourth quarter 2024 earnings results today. Net sales of $3.25 billion were up 14.9% year-over-year. Net income fell 29% to $22.8 million, or $0.05
Paychex reports higher revenue and profit for Q3 2025; earnings beat estimates
Paychex Inc. (NASDAQ: PAYX) reported an increase in revenues and earnings for the third quarter of 2025. Earnings also came in above analysts’ forecasts. Revenues of the Rochester-based human capital
DLTR Earnings: Key quarterly highlights from Dollar Tree’s Q4 2024 financial results
Dollar Tree, Inc. (NASDAQ: DLTR) reported its fourth quarter 2024 earnings results today. Net sales increased 0.7% year-over-year to $5 billion. Same-store net sales increased 2%. Net loss amounted to
